Eyal Lapidot - Mehadrin Director

MEDN Stock  ILA 11,440  1,920  4.16%   

Director

Mr. Eyal Lapidot serves as Director at Mehadrin Ltd. since May 6, 2010. Previously, he served as Chief Executive Officer of Delek Israel Fuel Co., a subsidiary of Delek Group Ltd., from July 17, 2005, to May 31, 2009. Mr. Lapidot has served as Chief Executive Officer of Direct I.D.I Insurance Company Ltd. from 2001 to 2005 since 2010.
Age 51
Tenure 14 years
Professional MarksMBA
Phone972 3 937 1300
Webhttps://www.mehadrin.co.il
Lapidot has a Bachelors Degree in Accounting and Economics and an MBA in Finance and Banking both from the TelAviv University. He is also a Certified Public Accountant.

Mehadrin Management Efficiency

The company has return on total asset (ROA) of 0.0784 % which means that it generated a profit of $0.0784 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 0.1895 %, meaning that it generated $0.1895 on every $100 dollars invested by stockholders. Mehadrin's management efficiency ratios could be used to measure how well Mehadrin manages its routine affairs as well as how well it operates its assets and liabilities.
The company has accumulated 422.83 M in total debt with debt to equity ratio (D/E) of 0.76, which is about average as compared to similar companies. Mehadrin has a current ratio of 1.16, suggesting that it may not be capable to disburse its financial obligations in time and when they become due. Debt can assist Mehadrin until it has trouble settling it off, either with new capital or with free cash flow. So, Mehadrin's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Mehadrin sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Mehadrin to invest in growth at high rates of return. When we think about Mehadrin's use of debt, we should always consider it together with cash and equity.

Similar Executives

Showing other executives

DIRECTOR Age

Ephraim KundaCellcom Israel
66
Elad ZadokDiscount Investment Corp
35
Michal KamirShufersal
50
Meir JacobsonDiscount Investment Corp
64
Shulamit BandelClal Insurance Enterprises
61
Ori JanoDiscount Investment Corp
34
Mishael VakninPropert Buil
45
Diana DanShufersal
53
Nochi DanknerPropert Buil
60
Saul LapidusDiscount Investment Corp
37
Mihael HaimShufersal
N/A
Ari BronshteinCellcom Israel
45
Ayelet EzerShufersal
51
Varda LibermanCellcom Israel
N/A
Alejandro ElsztainDiscount Investment Corp
51
Ronen ZadokShufersal
55
Gustavo TraiberCellcom Israel
57
Yehezkel DaskalPropert Buil
68
Niv AhituvDiscount Investment Corp
71
Saul ZangPropert Buil
72
Saul ZangDiscount Investment Corp
72
Mehadrin Ltd. grows and markets citrus, fruits, and vegetables primarily under JAFFA brand name in Israel. It owns and operates approximately 8,500 hectares of agricultural holdings. MEHADRIN is traded on Tel Aviv Stock Exchange in Israel. Mehadrin (MEDN) is traded on Tel Aviv Stock Exchange in Israel and employs 880 people.

Management Performance

Mehadrin Leadership Team

Elected by the shareholders, the Mehadrin's board of directors comprises two types of representatives: Mehadrin inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Mehadrin. The board's role is to monitor Mehadrin's management team and ensure that shareholders' interests are well served. Mehadrin's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Mehadrin's outside directors are responsible for providing unbiased perspectives on the board's policies.
Tomer Ezra, VP Products
Jonathan Bassi, Chairman of the Board
Roy Yakir, Director
Avraham Yehudayoff, External Director
Shirley Gabrieli, Chief Officer
Daniel Dardick, External Director
Natan Gilboa, External Director
Eyal Lapidot, Director
Jorge Lemcoff, External Director
Alejandro Larosa, Director
Sagie Eitan, Director
Ron Hyman, Director
Rafael Bisker, Director
Uri Alon, Independent Director
Michal Sapir, External Director
Guy Binstock, CEO
Ben Dan, Mang
Shaul Shelach, Chief Officer
Israel Sandler, Chief Executive Officer
Shalom Mahlab, Vice President - Finance
Amalia Ofir, Property Sec
Dan Nestor, Director
And Dan, Director
Alejandro Elsztain, Chairman of the Board
Ayelet Stolro, VP HR
Shalom Machlev, Chief Financial Officer
Serge Debua, Marketing Mang
Sivan Amnon, Deputy Marketing

Mehadrin Stock Performance Indicators

The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Mehadrin a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Architect
Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Mehadrin. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in board of governors.
You can also try the Instant Ratings module to determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance.

Complementary Tools for Mehadrin Stock analysis

When running Mehadrin's price analysis, check to measure Mehadrin's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Mehadrin is operating at the current time. Most of Mehadrin's value examination focuses on studying past and present price action to predict the probability of Mehadrin's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Mehadrin's price. Additionally, you may evaluate how the addition of Mehadrin to your portfolios can decrease your overall portfolio volatility.
Financial Widgets
Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets
Sectors
List of equity sectors categorizing publicly traded companies based on their primary business activities
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
Bond Analysis
Evaluate and analyze corporate bonds as a potential investment for your portfolios.
Economic Indicators
Top statistical indicators that provide insights into how an economy is performing
Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets
Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
Portfolio Analyzer
Portfolio analysis module that provides access to portfolio diagnostics and optimization engine
Stock Screener
Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.
Idea Analyzer
Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas
Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities
Content Syndication
Quickly integrate customizable finance content to your own investment portal
Performance Analysis
Check effects of mean-variance optimization against your current asset allocation
Please note, there is a significant difference between Mehadrin's value and its price as these two are different measures arrived at by different means. Investors typically determine if Mehadrin is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Mehadrin's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.